citalopram has been researched along with Bone Loss, Osteoclastic in 2 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fluoxetine (8." | 1.48 | Differential effects of serotonin reuptake inhibitors fluoxetine and escitalopram on bone markers and microarchitecture in Wistar rats. ( Kothari, P; Kumar, M; Trivedi, R; Vohora, D; Wadhwa, R, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, M | 1 |
| Wadhwa, R | 1 |
| Kothari, P | 1 |
| Trivedi, R | 1 |
| Vohora, D | 1 |
| Aydin, H | 1 |
| Mutlu, N | 1 |
| Akbas, NB | 1 |
2 other studies available for citalopram and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Differential effects of serotonin reuptake inhibitors fluoxetine and escitalopram on bone markers and microarchitecture in Wistar rats.
Topics: Animals; Antidepressive Agents; Biomarkers; Bone and Bones; Bone Density; Bone Resorption; Citalopra | 2018 |
Treatment of a major depression episode suppresses markers of bone turnover in premenopausal women.
Topics: Adolescent; Adult; Antidepressive Agents; Biomarkers; Bone Resorption; Calcium; Ciguatoxins; Citalop | 2011 |